Target Market Determination

The purpose of this Target Market Determination (“TMD”) is to comply with the Design and Distribution Obligations incorporated under Chapter 7 of the Corporations Act 2001 (“the Act”) by the Treasury Laws Amendment (Design and Distribution Obligations and Product Intervention Powers) Act 2019.
This document aims to provide information to anyone who wishes to become a member of Xtras Health Plan Savings Scheme (ARSN 627076411) for their extras only cover as an alternative to traditional extras health insurance cover. It also specifies how the product is distributed and the conditions that apply as well as the frequency of the Review of the TMD

a. Control out-of-pocket expenses associated with extras health needs,
b. Accumulate unused funds rather than lose it compare to traditional extras health insurance cover,
c. Budget for future health needs,
d. Access capped fees with health providers registered with the platform,
e. Use funds for non extras health needs. E.g. Hospital Gap Payments.

This product is not suitable for Hospital Cover, Overseas Student Cover or any type of health cover for Visa purpose either for visit, migration or work residency purpose.

The key attributes of Xtras Health Plan Savings Scheme are

For all the details on the scheme please read the PDS.

The Product, and its key attributes, is likely to be consistent with the likely objectives, financial situation and needs of members looking for an alternative to traditional extras health cover in the target market based on the following:

a. There is 53% of the Australian population who have extras cover,
b. Not all extras health services is used every year, resulting in loss of funds to holders of such extras health insurance cover,
c. Extras health needs increase over time,
d. Cost of extras health insurnace cover increases every year, whilst the rebates do not increase. 
e. Extras health insurance products have limits and caps that could result in increased out of pocket expenses.

This section is required under s994B(5)(c).

The only way to join the scheme is online via the website. There are no paper application forms or customer service centre or other representatives of the scheme.

To ensure that the products are sold in accordance with the TMD: see s994B(5)(c) and 994B(8)(a)], the issuer of the product has taken the following factors into consideration
1. Wide market for the product
2. The ability to restrict the use of the product being distributed by other means other than those adopted by the issuer. Namely the joining the scheme only via the website.

Xtras Health Plan Savings Scheme is designed with specific consideration and is only available for those who meet the eligibility requirements.
a. Must be verified under KYC requirements
b. Be an Australian Resident
c. Be an Australian Citizen
d. Be able to use online platform to interact and transact
e. Must have a mobile phone linked to the member’s account.

The minimum contribution to be a member of the scheme is $5 per day or $152 per month or $1825 per year. Other financial considerations for the consumer is as  below.
Platform Fee Annual recurring $199.00
Contribution Fee 1% of Contributions
Management Fee 0.5% of Monthly account balance.

The issuer of the scheme will review this TMD as per the following listed below.

This part is required under section 994B(5)(d) of the Act.
If events or circumstances occur that would reasonably suggest that the TMD is no longer appropriate, the Issuer will review the TMD. This may include:
• an event or circumstance that would materially affect the manner in which this TMD has been determined. This could be changes to existing regulatory environment or the way extras health services are provided in Australia due to to changes in health regulation. Other factors that may influence the changes to the TMD may include significant event such as stock market crash, changes to banking regulations or substantial changes to Government schemes that impact the operations of the scheme and its target market as determined.
• a material changes to the design or distribution of the Product
• a significant dealing in the Product that is not consistent with the product’s TMD
• the nature and extent of any feedback received from members of the scheme such as members asking for inclusion of additional services currently not provided by the scheme or rise in member complaints
• experiencing significant regulatory issues with industry bodies or government entities eg ASIC AFCA investigations

This part is required under section 994B(5)(e) and (f) of the Act.

Initial Review: This TMD will be reviewed within 12 months of the TMD approved date.

Periodic Reviews: This TMD will be reviewed at least every 5 years from the initial review date.

This part is required under s994B(5)(g) & (h).
Complaints
All complaints covered by this TMD will be reported to the product issuer on the same day it is received.
Significant Dealings
Any changes to the current method of distribution or significant changes in the product not consistent with this TMD within 10 business days.
Other information
Any referrer, who refers new members to the scheme will be required to provide information relevant to the scheme or referred to the PDS of the scheme.
Appropriateness of the TMD
This section is required under s994B(5)(c) and s994B(8)(a) &(b).
The Issuer has reviewed the Product and its key attributes by considering its purpose, past outcomes and likely future outcomes, and has reasonably concluded that the Product is likely to be consistent with the likely objectives, financial situation and needs of consumers in the target market as described above, when offered to the consumer in accordance with the distribution conditions listed above. The comparatively wide target market of the Issuer has been a factor in assessing why the distribution conditions and restrictions will make it likely that consumers who purchase the product are in the class of consumers for which it has been designed.